Drawing for ARCOXIA

USPTO serial 90367905

ARCOXIA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ATTANG, UDEME U
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ARCOXIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JOHN V. HOBGOOD, ESQUIRE

JOHN V. HOBGOOD, ESQUIRE WILMER CUTLER PICKERING HALE AND DORR LLP60 STATE STREETBOSTON, MA 02109United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of fever, pain, inflammation and arthritisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 10, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 10, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 13, 2024EX5GSOU EXTENSION 5 GRANTED—
Sep 13, 2024EXT5SOU EXTENSION 5 FILED—
Sep 13, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 16, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 15, 2024EX4GSOU EXTENSION 4 GRANTED—
Mar 15, 2024EXT4SOU EXTENSION 4 FILED—
Mar 15, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 14, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 12, 2023EX3GSOU EXTENSION 3 GRANTED—
Sep 12, 2023EXT3SOU EXTENSION 3 FILED—
Sep 12, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 16, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 14, 2023EX2GSOU EXTENSION 2 GRANTED—
Mar 14, 2023EXT2SOU EXTENSION 2 FILED—
Mar 14, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 17, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 15, 2022EX1GSOU EXTENSION 1 GRANTED—
Sep 15, 2022EXT1SOU EXTENSION 1 FILED—
Sep 15, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 15, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 1, 2022TMBNTTAB RELEASE CASE TO TRADEMARKS—
Feb 1, 2022OP.TOPPOSITION TERMINATED NO. 999999—
Feb 1, 2022OP.DOPPOSITION DISMISSED NO. 999999—
Nov 3, 2021OP.IOPPOSITION INSTITUTED NO. 999999—
Aug 3, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 7, 2021DOCKASSIGNED TO EXAMINER—
Jul 6, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 6, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 16, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 2, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 26, 2021DOCKASSIGNED TO EXAMINER—
Mar 16, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 16, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 16, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 16, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 16, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 16, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 13, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 11, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance